首页 | 本学科首页   官方微博 | 高级检索  
   检索      

葛根素联合小檗碱干预非酒精性脂肪性肝炎两种动物模型的病理学研究
引用本文:续 畅,马致洁,黄 凤,钟晓松.葛根素联合小檗碱干预非酒精性脂肪性肝炎两种动物模型的病理学研究[J].现代生物医学进展,2019,19(13):2414-2418.
作者姓名:续 畅  马致洁  黄 凤  钟晓松
作者单位:首都医科大学附属北京世纪坛医院临床基因与细胞工程中心;首都医科大学附属北京友谊医院中药剂科;首都医科大学附属北京中医医院针灸科
基金项目:北京市科技计划脑科学专项(Z161100000216136);国家自然科学基金青年科学基金项目(81503580)
摘    要:目的:从病理学的角度探讨葛根素及小檗碱对非酒精性脂肪性肝炎(NASH)的干预作用。方法:制备高脂饮食诱导的SD大鼠NASH模型及蛋氨酸-胆碱缺乏饮食诱导的C57BL/6小鼠NASH模型,各给药组造模并同时灌胃给药,大鼠持续8周后取材,小鼠持续2周后取材。肝组织制成石蜡切片进行HE染色,制成冰冻切片进行油红O染色,经光镜观察摄片后,采用NAFLD活动度积分对各组进行NASH评估。结果:HE及油红O检测提示葛根素联合小檗碱可减轻两种NASH动物模型肝脏的脂肪变性、抑制肝细胞空泡化的发生,减少肝小叶内炎性病灶的数量。给予葛根素联合小檗碱的SD大鼠NAS总分为2.60±0.52(3),给予葛根素联合小檗碱的C57BL/6小鼠NAS总分为2.80±0.79(3),均已排除NASH。结论:葛根素联合小檗碱可显著抑制NASH相关病理变化的发生发展,对NASH具有一定的干预作用。

关 键 词:葛根素  小檗碱  非酒精性脂肪性肝炎  大鼠  小鼠  病理学
收稿时间:2019/2/17 0:00:00
修稿时间:2019/3/14 0:00:00

Pathological Study of Puerarin Combined with Berberine on Two Animal Models of Non-alcoholic Steatohepatitis
XU Chang,MA Zhi-jie,HUANG Feng,ZHONG Xiao-song.Pathological Study of Puerarin Combined with Berberine on Two Animal Models of Non-alcoholic Steatohepatitis[J].Progress in Modern Biomedicine,2019,19(13):2414-2418.
Authors:XU Chang  MA Zhi-jie  HUANG Feng  ZHONG Xiao-song
Institution:Clinical Gene and Cell Engineering Center, Beijing Shijitan hospital, Capital Medical University, Beijing, 100038, China;Department of Traditional Chinese Medicine, Beijing Friendship hospital, Capital Medical University, Beijing, 100050, China;Department of Acipuncture and Moxibustion, Beijing Traditional Chinese Medicine hospital, Capital Medical University, Beijing, 100050, China
Abstract:ABSTRACT Objective: To investigate the effect of puerarin and berberine on non-alcoholic steatohepatitis (NASH) from the pathological point of view. Methods: The NASH model of SD rats induced by high fat diet, the NASH model of C57BL/6 mice induced by methionine-choline deficiency diet were prepared. Each treatment group was given intragastric administration while being modeled. The rats were dissected after 8 weeks and the mice were dissected after 2 weeks. Paraffin sections of liver tissue were stained with HE and frozen sections were stained with oil red O. After light microscopy, NAFLD activity score was used to evaluate NASH in each group. Results: HE and oil red O assay showed that puerarin combined with berberine could alleviate steatosis, inhibit vacuolation of hepatocytes and reduce the number of inflammatory lesions in hepatic lobules in two NASH animal models. The total NAS of SD rats treated with puerarin and berberine was 2.60 +0.52 (< 3), and the total NAS of C57BL/6 mice treated with puerarin and berberine was 2.80 +0.79 (< 3), which excluded NASH. Conclusion:Puerarin and berberine can significantly inhibit the occurrence and development of pathological changes related to NASH. They have a certain intervention effect on NASH.
Keywords:Puerarin  Berberine  Non-alcoholic Steatohepatitis  Rats  Mice  Pathology
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号